1.76
price up icon7.98%   0.13
after-market After Hours: 1.76
loading

Bioatla Inc Stock (BCAB) Forecast

The Bioatla Inc (BCAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $16.74, representing a +851.28% increase from the current price of $1.76. The highest analyst price target is $24.08, and the lowest is $9.4035.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCAB Price Target
Average 12.29 (+598.48% Upside)
loading

Is Bioatla Inc (BCAB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 53.04 Neutral
STOCH(9,6) 31.45 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -0.0197 Sell
ADX(14) 19.49 Neutral
William %R -30.00 Neutral
CCI(14) 12.82 Neutral
Buy: 0 Sell: 2 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.6785
Buy
1.6904
Buy
MA20
1.7313
Buy
1.7106
Buy
MA50
1.7111
Buy
1.7339
Buy
MA100
1.7675
Sell
1.8453
Sell
MA200
2.1814
Sell
2.037
Sell
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, BCAB could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on BCAB, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 53.04 indicates that BCAB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 31.45 indicates that BCAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BCAB is oversold. This suggests that BCAB price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 19.49 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 12.82 indicates that BCAB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term BCAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Bioatla Inc financial reports and earnings history, Bioatla Inc (BCAB) stock could reach $31.93 by 2030, $93.39 by 2040 and $78.05 by 2050. See the projected annual prices until 2050 of the Bioatla Inc stock below:

  • Bioatla Inc (BCAB) is expected to reach an average price of $23.78 in 2035, with a high prediction of $25.13 and a low estimate of $23.79. This indicates an $1,251% rise from the last recorded price of $1.76.
  • Bioatla Inc (BCAB) stock is projected to chart a bullish course in 2040, with an average price target of $93.41, representing an $5,207% surge from its current level. The forecast ranges from a conservative $94.50 to a sky-high $93.39.
  • Our analysts predict Bioatla Inc (BCAB) to jump 6,567% by 2045, soaring from $117.63 to an average price of $117.34, potentially reaching $117.99. While $117.63 is the low estimate, the potential upside is significant.
  • Bioatla Inc (BCAB) stock is expected to climb by 2050, reaching an average of $75.86, a $4,210% jump from its current level. However, a wide range of estimates exists, with high and low targets of $78.05 and $76.11, respectively, highlighting the market's uncertainty.

Bioatla Inc Stock (BCAB) Year by Year Forecast

Bioatla Inc Stock (BCAB) Price Forecast for 2024

Our forecast for BCAB stock price in 2024 now indicates an average price target of $23.67 with a high forecast of $47.04 and a low forecast of $0.298. The average prediction reflects an increase of +1,245% from the last recorded price of $1.76.
Month Average Low High Change from today's price
November, 2024 $15.06 $9.4035 $24.08 +755.54%
December, 2024 $14.52 $10.39 $16.96 +724.74%

Bioatla Inc Stock (BCAB) Price Forecast for 2025

Bioatla Inc Stock (BCAB) is expected to reach an average price of $8.9873 in 2025, with a high prediction of $17.47 and a low estimate of $0.505. This indicates an +410.64% rise from the last recorded price of $1.76.
Month Average Low High Change from today's price
January, 2025 $14.82 $11.44 $17.40 +741.78%
February, 2025 $9.0732 $9.0332 $16.52 +415.52%
March, 2025 $1.9111 $0.9136 $8.9552 +8.59%
April, 2025 $3.701 $0.8531 $6.9141 +110.29%
May, 2025 $1.131 $0.505 $5.313 -35.74%
June, 2025 $3.4331 $2.739 $2.5131 +95.06%
July, 2025 $12.79 $7.491 $12.77 +626.89%
August, 2025 $15.15 $14.53 $14.86 +760.53%
September, 2025 $15.45 $15.30 $15.27 +777.69%
October, 2025 $16.51 $16.00 $15.73 +837.92%
November, 2025 $17.64 $16.69 $17.47 +902.25%
December, 2025 $16.28 $16.61 $17.36 +824.98%

Bioatla Inc Stock (BCAB) Price Forecast for 2026

The predicted value for Bioatla Inc (BCAB) in 2026 is set at an average of $10.61. Estimates vary from a peak of $16.21 to a trough of $5.0222, indicating an +503.12% surge from the present price of $1.76.
Month Average Low High Change from today's price
January, 2026 $15.72 $15.87 $16.21 +793.28%
February, 2026 $14.69 $14.46 $14.43 +734.87%
March, 2026 $8.4458 $9.3658 $13.98 +379.88%
April, 2026 $8.8059 $8.9759 $8.5319 +400.34%
May, 2026 $9.448 $9.097 $9.033 +436.82%
June, 2026 $6.7001 $8.3901 $9.131 +280.69%
July, 2026 $5.4602 $5.0222 $5.3581 +210.24%
August, 2026 $6.1722 $6.1682 $5.8362 +250.70%
September, 2026 $9.4223 $9.9473 $10.60 +435.36%
October, 2026 $10.14 $9.9904 $10.00 +476.39%
November, 2026 $10.20 $10.22 $10.04 +479.35%
December, 2026 $8.4766 $8.5766 $9.5945 +381.62%

Bioatla Inc Stock (BCAB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Bioatla Inc (BCAB) is $4.8216, with a high forecast of $7.8246 and a low forecast of $1.8186. This indicates an +173.95% increase from the last price of $1.76.
Month Average Low High Change from today's price
January, 2027 $8.1887 $8.2006 $7.8246 +365.26%
February, 2027 $6.9307 $7.2607 $7.8066 +293.79%
March, 2027 $7.0708 $7.1388 $7.2298 +301.75%
April, 2027 $6.7629 $6.8369 $6.8588 +284.26%
May, 2027 $6.245 $6.375 $6.5509 +254.83%
June, 2027 $6.3951 $6.343 $6.3921 +263.36%
July, 2027 $6.1171 $6.2811 $6.1541 +247.57%
August, 2027 $5.4292 $5.4792 $5.4952 +208.48%
September, 2027 $4.0793 $4.4493 $4.9672 +131.78%
October, 2027 $3.7614 $3.6284 $3.3404 +113.72%
November, 2027 $2.4235 $2.9835 $3.4094 +37.70%
December, 2027 $1.6936 $1.8186 $2.3795 -3.78%

Bioatla Inc Stock (BCAB) Price Forecast for 2028

In 2028, Bioatla Inc (BCAB) is projected to reach an average price of $14.38, with a high projection of $28.21 and a low estimate of $0.5461. This indicates an +716.82% rise from the last price of $1.76.
Month Average Low High Change from today's price
January, 2028 $0.0956 $0.7256 $1.5796 -94.57%
February, 2028 $1.0727 $0.6437 $0.9197 -39.05%
March, 2028 $23.78 $0.9257 $28.21 +1,251%
April, 2028 $13.04 $17.84 $13.34 +641.04%
May, 2028 $6.9376 $9.4943 $9.0176 +294.18%
June, 2028 $7.2466 $0.5461 $17.44 +311.74%
July, 2028 $7.6107 $8.7007 $6.7337 +332.43%
August, 2028 $14.08 $13.05 $11.95 +700.05%
September, 2028 $12.27 $12.53 $12.08 +596.88%
October, 2028 $12.24 $12.72 $11.69 +595.41%
November, 2028 $11.23 $13.99 $11.09 +538.04%
December, 2028 $16.40 $10.92 $11.71 +832.02%

Bioatla Inc Stock (BCAB) Price Forecast for 2029

The 2029 price forecast for Bioatla Inc Stock (BCAB) is $29.00 on average, with a high prediction of $37.41 and a low estimate of $20.58. This represents an +1,547% increase from the previous price of $1.76.
Month Average Low High Change from today's price
January, 2029 $21.11 $21.57 $20.13 +1,100%
February, 2029 $20.50 $20.58 $19.76 +1,065%
March, 2029 $24.76 $21.72 $22.12 +1,307%
April, 2029 $26.50 $26.23 $25.58 +1,405%
May, 2029 $35.15 $30.41 $35.13 +1,897%
June, 2029 $36.93 $36.74 $36.65 +1,998%
July, 2029 $36.66 $36.95 $36.63 +1,983%
August, 2029 $37.01 $36.65 $36.47 +2,003%
September, 2029 $37.58 $37.05 $37.41 +2,035%
October, 2029 $35.51 $35.84 $37.16 +1,918%
November, 2029 $34.38 $34.53 $35.30 +1,854%
December, 2029 $32.79 $32.69 $32.95 +1,763%

Bioatla Inc Stock (BCAB) Price Forecast for 2030

Bioatla Inc Stock (BCAB) is expected to reach an average price of $24.95 in 2030, with a high forecast of $31.93 and a low forecast of $17.97. This signifies an +1,318% surge from the last price of $1.76.
Month Average Low High Change from today's price
January, 2030 $26.06 $26.61 $31.93 +1,381%
February, 2030 $25.62 $25.79 $25.77 +1,356%
March, 2030 $25.70 $25.63 $25.28 +1,360%
April, 2030 $22.38 $24.07 $25.24 +1,172%
May, 2030 $20.43 $20.13 $20.90 +1,061%
June, 2030 $20.57 $21.00 $20.52 +1,069%
July, 2030 $23.11 $23.64 $24.72 +1,213%
August, 2030 $23.27 $23.38 $23.13 +1,222%
September, 2030 $22.75 $22.88 $22.89 +1,193%
October, 2030 $20.32 $20.42 $22.01 +1,055%
November, 2030 $19.47 $19.62 $19.53 +1,006%
December, 2030 $17.64 $17.97 $18.94 +902.36%
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
Cap:     |  Volume (24h):